Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia

Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia

10.1038/bcj.2011.43

Saved in:
Bibliographic Details
Main Authors: Hart, S., Goh, K.C., Novotny-Diermayr, V., Tan, Y.C., Madan, B., Amalini, C., Ong, L.C., Kheng, B., Cheong, A., Zhou, J., Chng, W.J., Wood, J.M.
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: 2014
Subjects:
AML
FLT3
JAK2
Pacritinib
SB1518
Online Access:http://scholarbank.nus.edu.sg/handle/10635/117115
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-117115
record_format dspace
spelling sg-nus-scholar.10635-1171152023-10-25T07:28:38Z Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia Hart, S. Goh, K.C. Novotny-Diermayr, V. Tan, Y.C. Madan, B. Amalini, C. Ong, L.C. Kheng, B. Cheong, A. Zhou, J. Chng, W.J. Wood, J.M. CANCER SCIENCE INSTITUTE OF SINGAPORE AML FLT3 JAK2 Pacritinib SB1518 10.1038/bcj.2011.43 Blood Cancer Journal 1 11 - 2014-12-12T08:01:43Z 2014-12-12T08:01:43Z 2011-11 Article Hart, S., Goh, K.C., Novotny-Diermayr, V., Tan, Y.C., Madan, B., Amalini, C., Ong, L.C., Kheng, B., Cheong, A., Zhou, J., Chng, W.J., Wood, J.M. (2011-11). Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia. Blood Cancer Journal 1 (11) : -. ScholarBank@NUS Repository. https://doi.org/10.1038/bcj.2011.43 20445385 http://scholarbank.nus.edu.sg/handle/10635/117115 000298892000001 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic AML
FLT3
JAK2
Pacritinib
SB1518
spellingShingle AML
FLT3
JAK2
Pacritinib
SB1518
Hart, S.
Goh, K.C.
Novotny-Diermayr, V.
Tan, Y.C.
Madan, B.
Amalini, C.
Ong, L.C.
Kheng, B.
Cheong, A.
Zhou, J.
Chng, W.J.
Wood, J.M.
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
description 10.1038/bcj.2011.43
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Hart, S.
Goh, K.C.
Novotny-Diermayr, V.
Tan, Y.C.
Madan, B.
Amalini, C.
Ong, L.C.
Kheng, B.
Cheong, A.
Zhou, J.
Chng, W.J.
Wood, J.M.
format Article
author Hart, S.
Goh, K.C.
Novotny-Diermayr, V.
Tan, Y.C.
Madan, B.
Amalini, C.
Ong, L.C.
Kheng, B.
Cheong, A.
Zhou, J.
Chng, W.J.
Wood, J.M.
author_sort Hart, S.
title Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
title_short Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
title_full Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
title_fullStr Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
title_full_unstemmed Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
title_sort pacritinib (sb1518), a jak2/flt3 inhibitor for the treatment of acute myeloid leukemia
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/117115
_version_ 1781789597614735360

Similar Items